BSA-PLGA-based core-shell nanoparticles as carrier system for water-soluble drugs

Pharmaceutical Research

Volumn 30, Issue 9, 2013, Pages 2396-2409

  Chitkara, Deepak ^a   Kumar, Neeraj ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

BSA; core shell nanoparticles; gemcitabine; water soluble drugs

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; BOVINE SERUM ALBUMIN POLYGLACTIN BASED CORE SHELL NANOPARTICLE; GEMCITABINE; NANOCARRIER; UNCLASSIFIED DRUG;

ARTICLE; CELL ASSAY; CELL TRANSPORT; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY TEST; DIFFERENTIAL SCANNING CALORIMETRY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG FORMULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROPHILICITY; HYDROPHOBICITY; IC 50; IN VITRO STUDY; NANOANALYSIS; NANOEMULSION; NANOFABRICATION; NANOPHARMACEUTICS; OSTEOSARCOMA CELL; PARTICLE SIZE; PRIORITY JOURNAL; PROCESS OPTIMIZATION; STRUCTURE ANALYSIS; SUSTAINED DRUG RELEASE; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION;

ANTIMETABOLITES, ANTINEOPLASTIC; CELL LINE, TUMOR; CELL SURVIVAL; DEOXYCYTIDINE; DRUG CARRIERS; HUMANS; LACTIC ACID; NANOPARTICLES; OSTEOSARCOMA; POLYGLYCOLIC ACID; SERUM ALBUMIN, BOVINE; SOLUBILITY; WATER;

EID: 84883272756     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-013-1084-6     Document Type: Article

References (42)

1. Allen TM, Cullis PR. Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliv Rev. 2012; In press. doi: 10.1016/j.addr.2012.09.037
2. Ayen WY, Garkhal K, Kumar N. Doxorubicin-loaded (PEG)(3)-PLA nanopolymersomes: effect of solvents and process parameters on formulation development and in vitro study. Mol Pharm. 2011;8(2):466-78.
3. Ayen WY, Chintankumar B, Jain JP, Kumar N. Effect of PEG chain length and hydrophilic weight fraction on polymersomes prepared from branched (PEG)3-PLA co-polymers. Polym Adv Technol. 2011;22(1):158-65.
4. Jain JP, Kumar N. Self assembly of amphiphilic (PEG)(3)-PLA copolymer as polymersomes: preparation, characterization, and their evaluation as drug carrier. Biomacromolecules. 2010;11(4):1027-35.
5. Ayen WY, Kumar N. In vivo evaluation of doxorubicin-loaded (PEG)(3)-PLA nanopolymersomes (PolyDoxSome) using DMBA-induced mammary carcinoma rat model and comparison with marketed LipoDox. Pharm Res. 2012;29(9):2522-33.
6. Jeong Y-I, Cheon J-B, Kim S-H, Nah J-W, Lee Y-M, Sung Y-K, et al. Clonazepam release from core-shell type nanoparticles in vitro. J Control Release. 1998;51(2-3):169-78.
7. Chan JM, Zhang L, Yuet KP, Liao G, Rhee JW, Langer R, et al. PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery. Biomaterials. 2009;30(8):1627-34.
8. Chitkara D, Singh S, Kumar V, Danquah M, Behrman SW, Kumar N, et al. Micellar delivery of cyclopamine and Gefitinib for treating pancreatic cancer. Mol Pharm. 2012;9(8):2350-7.
9. Chitkara D, Nikalaje SK, Mittal A, Chand M, Kumar N. Development of quercetin nanoformulation and in vivo evaluation using streptozotocin induced diabetic rat model. Drug Dev Trans Res. 2012;2(2):112-23.
10. Lee JY, Lee SH, Oh MH, Kim JS, Park TG, Nam YS. Prolonged gene silencing by siRNA/chitosan-g-deoxycholic acid polyplexes loaded within biodegradable polymer nanoparticles. J Control Release. 2012;162(2):407-13.
11. Steinbach JM, Weller CE, Booth CJ, Saltzman WM. Polymer nanoparticles encapsulating siRNA for treatment of HSV-2 genital infection. J Control Release. 2012;162(1):102-10.
12. Barichello JM, Morishita M, Takayama K, Nagai T. Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method. Drug Dev Ind Pharm. 1999;25(4):471-6.
13. Zhang Z, Huey Lee S, Feng SS. Folate-decorated poly(lactide-co-glycolide) -vitamin E TPGS nanoparticles for targeted drug delivery. Biomaterials. 2007;28(10):1889-99.
14. Tewes F, Munnier E, Antoon B, Ngaboni Okassa L, Cohen-Jonathan S, Marchais H, et al. Comparative study of doxorubicin-loaded poly(lactide-co- glycolide) nanoparticles prepared by single and double emulsion methods. Eur J Pharm Biopharm. 2007;66(3):488-92.
15. Leo E, Brina B, Forni F, Vandelli MA. In vitro evaluation of PLA nanoparticles containing a lipophilic drug in water-soluble or insoluble form. Int J Pharm. 2004;278(1):133-41.
16. Ubrich N, Bouillot P, Pellerin C, Hoffman M, Maincent P. Preparation and characterization of propranolol hydrochloride nanoparticles: a comparative study. J Control Release. 2004;97(2):291-300.
17. Khiati S, Luvino D, Oumzil K, Chauffert B, Camplo M, Barthelemy P. Nucleoside-lipid-based nanoparticles for cisplatin delivery. ACS Nano. 2011;5(11):8649-55.
18. Kashi TS, Eskandarion S, Esfandyari-Manesh M, Marashi SM, Samadi N, Fatemi SM, et al. Improved drug loading and antibacterial activity of minocycline-loaded PLGA nanoparticles prepared by solid/oil/water ion pairing method. Int J Nanomedicine. 2012;7(1):221-34.
19. Cavalli R, Bargoni A, Podio V, Muntoni E, Zara GP, Gasco MR. Duodenal administration of solid lipid nanoparticles loaded with different percentages of tobramycin. J Pharm Sci. 2003;92(5):1085-94.
20. Chavanpatil MD, Khdair A, Patil Y, Handa H, Mao G, Panyam J. Polymer-surfactant nanoparticles for sustained release of water-soluble drugs. J Pharm Sci. 2007;96(12):3379-89.
21. Vrignaud S, Benoit JP, Saulnier P. Strategies for the nanoencapsulation of hydrophilic molecules in polymer-based nanoparticles. Biomaterials. 2011;32(33):8593-604.
22. Chen Y, Chen H, Zeng D, Tian Y, Chen F, Feng J, et al. Core/shell structured hollow mesoporous nanocapsules: a potential platform for simultaneous cell imaging and anticancer drug delivery. ACS Nano. 2010;4(10):6001-13.
23. Hu SH, Chen SY, Gao X. Multifunctional nanocapsules for simultaneous encapsulation of hydrophilic and hydrophobic compounds and on-demand release. ACS Nano. 2012;6(3):2558-65.
24. Liu M, Gan L, Chen L, Xu Z, Zhu D, Hao Z, et al. Supramolecular core-shell nanosilica@liposome nanocapsules for drug delivery. Langmuir. 2012;28(29):10725-32.
25. Zhu J, Tang A, Law LP, Feng M, Ho KM, Lee DK, et al. Amphiphilic core-shell nanoparticles with poly(ethylenimine) shells as potential gene delivery carriers. Bioconjug Chem. 2005;16(1):139-46.
26. Oh KS, Han SK, Lee HS, Koo HM, Kim RS, Lee KE, et al. Core/shell nanoparticles with lecithin lipid cores for protein delivery. Biomacromolecules. 2006;7(8):2362-7.
27. Arias JL, Gallardo V, Ruiz MA, Delgado AV. Magnetite/ poly(alkylcyanoacrylate) (core/shell) nanoparticles as 5-fluorouracil delivery systems for active targeting. Eur J Pharm Biopharm. 2008;69(1):54-63.
28. Reddy LH, Couvreur C. Novel approaches to deliver gemcitabine to cancer. Curr Pharm Des. 2008;14(11):1124-37.
29. Okino H, Maeyama R, Manabe T, Matsuda T, Tanaka M. Trans-tissue, sustained release of gemcitabine from photocured gelatin Gel inhibits the growth of heterotopic human pancreatic tumor in nude mice. Clin Cancer Res. 2003;9(15):5786-93.
30. Celano M, Cavalgno MG, Bulotta S, Paolino D, Arturi F. Cytotoxic effects of gemcitabine-loaded liposomes in human anaplastic thyroid carcinoma cells. BMC Cancer. 2004;4(1):63-70.
31. Cavallaro G, Mariano L, Salmaso S, Caliceti P, Gaetano G. Folate-mediated targeting of polymeric conjugates of gemcitabine. Int J Pharm. 2006;307(1-2):258-69.
32. Patra CR, Bhattacharya R, Wang E, Katarya A, Lau JS, Dutta S, et al. Targeted delivery of gemcitabine to pancreatic adenocarcinoma using cetuximab as a targeting agent. Cancer Res. 2008;68(6):1970-8.
33. Yang J, Park S-B, Yoon H-G, Huh Y-M, Haam S. Preparation of poly caprolactone nanoparticles containing magnetite for magnetic drug carrier. Int J Pharm. 2006;324(2):185-90.
34. Song C, Labhasetwar V, Cui X, Underwood T, Levy RJ. Arterial uptake of biodegradable nanoparticles for intravascular local drug delivery: results with an acute dog model. J Control Release. 1998;54(2):201-11.
35. Hosseinzadeh H, Atyabi F, Dinarvand R, Ostad SN. Chitosan-pluronic nanoparticles as oral delivery of anticancer gemcitabine: preparation and in vitro study. Int J Nanomedicine. 2012;7(1):1851-63.
36. Kandagal PB, Ashoka S, Seetharamappa J, Shaikh SMT, Jadegoud Y, Ijare OB. Study of the interaction of an anticancer drug with human and bovine serum albumin: Spectroscopic approach. J Pharm Biomed Anal. 2006;41(2):393-9.
37. Lamprecht A, Ubrich N, Pérez MH, Lehr C-M, Hoffman M, Maincent P. Influences of process parameters on nanoparticle preparation performed by a double emulsion pressure homogenization technique. Int J Pharm. 2000;196(2):177-82.
38. Guhagarkar SA, Malshe VC, Devarajan PV. Nanoparticles of polyethylene sebacate: a new biodegradable polymer. AAPS PharmSciTech. 2009;10(3):935-42.
39. Lamprecht A, Ubrich N, Yamamoto H, Schafer U, Takeuchi H, Lehr CM, et al. Design of rolipram-loaded nanoparticles: comparison of two preparation methods. J Control Release. 2001;71(3):297-306.
40. Braakhuis BJ, Ruiz van Haperen VW, Boven E, Veerman G, Peters GJ. Schedule-dependent antitumor effect of gemcitabine in in vivo model system. Semin Oncol. 1995;22(4 Suppl 11):42-6.
41. dos Santos T, Varela J, Lynch I, Salvati A, Dawson KA. Effects of transport inhibitors on the cellular uptake of carboxylated polystyrene nanoparticles in different cell lines. PLoS One. 2011;6(9):e24438.
42. Alexander RL, Greene BT, Torti SV, Kucera GL. A novel phospholipid gemcitabine conjugate is able to bypass three drug-resistance mechanisms. Cancer Chemother Pharmacol. 2005;56(1):15-21.